TYK2 encodes a member of the tyrosine kinase specifically for the Janus kinases (JAKs) protein families, and inhibition of JAK1/JAK3 may provide an efficient therapeutic agent for the treatment of inflammatory diseases33 which might benefit AD patients as well since inflammation drives progression of AD34. Here, TYK2 is linked to Alzheimer disease.